For the Quarter Ending March 2026
Escitalopram Oxalate Prices in North America
- In United States, the Escitalopram Oxalate Price Index rose quarter-over-quarter in Q1 2026, driven by elevated precursor costs.
- The Escitalopram Oxalate Production Cost Trend increased in March 2026 as producer prices rose 4.0 percent year-over-year.
- A 3.3 percent consumer inflation increase in March 2026 elevated transportation expenses for Escitalopram Oxalate distribution networks.
- The Escitalopram Oxalate Demand Outlook strengthened in March 2026, supported by a 4.0 percent rise in retail sales.
- Stable 4.3 percent unemployment and a 91.8 consumer confidence index in March 2026 sustained Escitalopram Oxalate prescription adherence.
- Industrial production grew 0.7 percent and the Manufacturing Index expanded in March 2026, supporting Escitalopram Oxalate synthesis.
- Benzene prices surged in March 2026, intensifying the production cost burden for downstream Escitalopram Oxalate synthesis.
- The Escitalopram Oxalate Price Forecast indicated an upward trajectory in Q1 2026 due to constrained precursor inventories.
Why did the price of Escitalopram Oxalate change in March 2026 in North America?
- Upstream naphtha and reformate feedstock costs strengthened throughout Q1 2026, elevating Escitalopram Oxalate manufacturing expenses.
- Port inventories of key chemical precursors declined in March 2026, constraining material for API synthesis.
- Trade flows of active pharmaceutical ingredients fluctuated in January 2026 amid US import tariff exemptions.
Escitalopram Oxalate Prices in APAC
- In China, the Escitalopram Oxalate Price Index rose quarter-over-quarter in Q1 2026, driven by rising feedstock costs.
- The Escitalopram Oxalate Production Cost Trend increased as the Producer Price Index rose 0.5% in March 2026.
- The Escitalopram Oxalate Demand Outlook strengthened alongside a 1.0% Consumer Price Index increase in March 2026.
- Industrial production grew 5.7% in March 2026, which ensured stable domestic supply chains for Escitalopram Oxalate synthesis.
- The unemployment rate reached 5.4% in March 2026, which historically correlated with higher clinical Escitalopram Oxalate demand.
- Retail sales grew 1.7% in March 2026, which reflected softer consumer spending that slightly impacted pharmaceutical purchases.
- Consumer confidence registered at 91.6 in February 2026, which reflected economic caution that boosted anti-anxiety medication demand.
- Orthoxylene and mixed xylenes feedstock costs for Escitalopram Oxalate strengthened during February and March 2026.
- The Escitalopram Oxalate Price Forecast indicated an upward trajectory following the expanding Manufacturing Index in March 2026.
Why did the price of Escitalopram Oxalate change in March 2026 in APAC?
- Orthoxylene and mixed xylenes feedstock costs for Escitalopram Oxalate strengthened significantly during the month of March 2026.
- Global demand for Chinese-manufactured active pharmaceutical ingredients strengthened considerably during the month of March 2026.
- Middle Eastern petrochemical export flows to China stalled, tightening chemical precursor availability in March 2026.
Escitalopram Oxalate Prices in Europe
- In Germany, the Escitalopram Oxalate Price Index rose quarter-over-quarter in Q1 2026, driven by escalating feedstock costs.
- The Escitalopram Oxalate Production Cost Trend increased as European toluene feedstock costs accelerated sharply in March 2026.
- Higher inflation, with CPI at 2.7% in March 2026, increased operational and utility costs for API synthesis.
- The Escitalopram Oxalate Demand Outlook remained robust, supported by a stable 4.2% unemployment rate in February 2026.
- Modest retail sales growth of 0.7% in February 2026 sustained steady pharmacy dispensing and healthcare spending.
- Negative consumer confidence at -24.7 in March 2026 drove counter-cyclical demand for antidepressant medications like Escitalopram Oxalate.
- A -0.2% PPI decline in March 2026 and 0.0% industrial production in February 2026 stabilized the Escitalopram Oxalate Price Index.
- The Escitalopram Oxalate Price Forecast incorporated upward cost pressures as the Manufacturing Index expanded in March 2026.
Why did the price of Escitalopram Oxalate change in March 2026 in Europe?
- European TTF natural gas prices strengthened significantly in March 2026, elevating API manufacturing energy expenses.
- Toluene feedstock costs accelerated sharply in March 2026 due to crude-linked escalation and refinery maintenance.
- Pharmaceutical preparation producer prices surged to a record peak in February 2026, driving market values.
For the Quarter Ending December 2025
Escitalopram Oxalate Prices in North America
- In the United States, the Escitalopram Oxalate Price Index rose in Q4 2025, driven by increasing production costs and stable demand.
- Escitalopram Oxalate production costs increased in Q4 2025, influenced by a 3.0% PPI rise in November 2025.
- Demand for Escitalopram Oxalate remained stable in Q4 2025, supported by a 4.4% unemployment rate in December 2025.
- Henry Hub natural gas prices strengthened in November and December 2025, increasing energy inputs for chemical production.
- General inflation, with CPI rising 2.7% year-over-year in December 2025, contributed to higher raw material expenses.
- Overall industrial production increased by 2.0% year-over-year in December 2025, supporting pharmaceutical manufacturing stability.
- US imports and exports of pharmaceutical preparations decreased in October 2025, impacting overall trade dynamics.
- Total Industrial Production inched up in Q4 2025, with Capacity Utilization also rising in December 2025.
Why did the price of Escitalopram Oxalate change in December 2025 in North America?
- Rising production costs in Q4 2025, driven by a 3.0% PPI increase in November 2025, impacted Escitalopram Oxalate pricing.
- Strengthening Henry Hub natural gas prices in November and December 2025 elevated energy expenses for chemical manufacturing.
- A 2.7% CPI rise in December 2025 reflected broader inflationary pressures on raw materials and operational overheads.
Escitalopram Oxalate Prices in APAC
- In China, the Escitalopram Oxalate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer costs.
- Escitalopram Oxalate production costs decreased in Q4 2025, with producer prices falling 1.9% year-over-year in December 2025.
- Demand for Escitalopram Oxalate remained stable in Q4 2025, supported by healthy global Active Pharmaceutical Ingredient market growth.
- China's manufacturing index expanded in December 2025, indicating a healthy industrial environment for Escitalopram Oxalate supply.
- Industrial production grew 5.2% year-over-year in December 2025, supporting robust Escitalopram Oxalate production volumes.
- Overall chemical input costs faced downward pressure in 2025 due to oversupply, impacting Escitalopram Oxalate production expenses.
- Chinese electricity prices experienced downward pressure in Q4 2025, contributing to lower energy costs for manufacturing.
- Asian spot LNG prices climbed in November 2025, exerting upward pressure on some energy-related production costs.
- China's chemical exports increased between October and November 2025, reflecting strong external demand for chemical products.
- The prices for Escitalopram Oxalate in Q4, 2025 settled at USD 2160/MT in Asia.
Why did the price of Escitalopram Oxalate change in December 2025 in APAC?
- Producer prices declined 1.9% year-over-year in December 2025, reducing Escitalopram Oxalate manufacturing costs.
- Overall chemical input costs faced downward pressure in 2025 due to oversupply, lowering production expenses.
- Low consumer inflation at 0.8% year-over-year in December 2025 indicated broader economic weakness.
Escitalopram Oxalate Prices in Europe
- In Germany, the Escitalopram Oxalate Price Index fell quarter-over-quarter in Q4 2025, influenced by declining industrial producer prices.
- Escitalopram Oxalate production costs faced downward pressure from a -2.5% Producer Price Index in December 2025.
- Demand for Escitalopram Oxalate was supported by increased pharmaceutical output in Germany during 2025.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in overall economic activity.
- Consumer confidence remained significantly negative at -17.5 in December 2025, impacting healthcare spending.
- Elevated European natural gas prices in 2025 contributed to uncompetitive production costs for the German chemical industry.
- Industrial production grew by 0.8% in October 2025, while retail sales increased by 1.1% in November 2025.
- A stable Consumer Price Index at 1.8% in December 2025 supported overall economic stability despite moderate unemployment.
Why did the price of Escitalopram Oxalate change in December 2025 in Europe?
- Declining industrial producer prices, down 2.5% in December 2025, reduced Escitalopram Oxalate manufacturing input costs.
- A contracting Manufacturing Index in December 2025 and negative consumer confidence dampened overall demand.
- Elevated European natural gas prices in 2025 contributed to uncompetitive production costs for the German chemical sector.
For the Quarter Ending September 2025
Escitalopram Oxalate Prices in APAC
- In China, the Escitalopram Oxalate Price Index fell in Q3 2025, influenced by a -2.3% year-on-year decline in producer prices.
- Production costs showed mixed trends, with naphtha feedstock firming and natural gas prices rising in Q3 2025.
- Demand for Escitalopram Oxalate was supported by rising chronic disease treatments and bolstered psychiatric care.
- The Manufacturing Index was Contracting in September 2025, while industrial production expanded by 6.5% year-on-year.
- Retail sales increased by 3.0% year-on-year in September 2025, despite a -0.3% year-on-year CPI decrease.
- The unemployment rate was 5.2% in September 2025, suggesting some economic pressure on consumers.
- Domestic inventories remained comfortable in Q3 2025, with US tariffs expected to elevate API costs.
- Escitalopram Oxalate price forecast remains under pressure, reflecting bearish consumer confidence (89.6 in September 2025).
Why did the price of Escitalopram Oxalate change in September 2025 in APAC?
- Producer prices declined -2.3% year-on-year in September 2025, contributing to lower input costs.
- Naphtha feedstock costs firmed and natural gas prices rose in Q3 2025, increasing production expenses.
- Strong demand for chronic disease treatments was partially countered by contracting manufacturing activity.
Escitalopram Oxalate Prices in Europe
- In Germany, the Escitalopram Oxalate Price Index fell in Q3 2025, influenced by declining industrial production.
- Escitalopram Oxalate production costs faced mixed pressures, with producer prices falling 1.7% in September 2025.
- Demand was constrained by Germany's stagnating economic activity and industrial production declining 1.0% in September 2025.
- The Escitalopram Oxalate Price Index is forecast to remain stable due to market overcapacity in Q3 2025.
- Germany's Manufacturing Index was contracting in Q3 2025, reflecting a broader economic slowdown.
- European natural gas prices declined year-on-year in Q3 2025, easing some Escitalopram Oxalate production costs.
- Overcapacity in the European chemical industry and declining German exports impacted Escitalopram Oxalate trade.
- Consumer Price Index rose 2.4% in September 2025, increasing general manufacturing and distribution costs.
Why did the price of Escitalopram Oxalate change in September 2025 in Europe?
- Producer prices fell 1.7% in September 2025, reducing Escitalopram Oxalate manufacturing costs.
- Germany's Manufacturing Index contracted in Q3 2025, signaling weaker industrial demand.
- European chemical overcapacity and declining German exports pressured Escitalopram Oxalate prices.
Escitalopram Oxalate Prices in North America
- In the United States, Escitalopram Oxalate Price Index rose in Q3 2025, driven by robust demand and rising costs.
- Price Forecast suggests continued upward pressure from sustained healthcare spending and increasing input expenses.
- Production costs increased, influenced by a 2.6% PPI rise in August 2025 and higher natural gas feedstock.
- Demand outlook remained strong, supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
- General inflation, with CPI up 3.0% year-over-year in September 2025, impacted operational costs.
- Biopharma industry momentum gathered in Q3 2025, with new US FDA drug approvals boosting demand.
- Trade flows faced disruption from tariff uncertainty in Q3 2025; US chemical exports and imports softened.
- Industrial production increased 0.1% year-on-year in September 2025, indicating stable manufacturing activity.
- Consumer confidence declined to 94.2 in September 2025, potentially affecting patient treatment seeking.
Why did the price of Escitalopram Oxalate change in September 2025 in North America?
- Rising production costs, with PPI up 2.6% in August 2025, directly impacted manufacturing expenses.
- Strong consumer spending, retail sales up 5.42% in September 2025, bolstered patient access and demand.
- General inflation, CPI rising 3.0% in September 2025, contributed to higher operational and raw material costs.
